Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

26 oct 2026 7:30 a.m. - 27 oct 2026 4:00 p.m.

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 2, Track A: Move from Reactive to Resilient - Canada’s Strategic Vision for Supply Chain Security and Global Harmonization

Session Chair(s)

Rebecca  Humecky

Rebecca Humecky

Associate Director, Regulatory Affairs CMC, Cytokinetics Inc., United States

Oxana  Iliach, PhD

Oxana Iliach, PhD

Senior Director Regulatory Strategy, Certara, Canada

Drug shortages and supply chain disruptions have exposed critical vulnerabilities in how medicines are sourced, manufactured, and distributed worldwide, prompting Canada to rethink its approach from reactive crisis management to proactive resilience. This session brings together diverse perspectives to examine the root causes of supply chain fragility and the global harmonization efforts underway to strengthen quality standards and reduce shortage risk. Speakers will discuss practical strategies for risk mitigation, including diversified sourcing, early-warning systems, and cross-border regulatory cooperation, while highlighting Canada's role in shaping a more resilient and secure pharmaceutical supply chain. Attendees will gain actionable insight into how aligning Canadian policy with international standards can help prevent future shortages and protect patient access to essential medicines.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify key causes driving drug shortages and supply chain disruptions in the Canadian market
  • Examine harmonization strategies and compendial standards that support proactive risk mitigation across supply chains
  • Apply resilience-building frameworks to strengthen sourcing diversification and early-warning systems within drug development programs

Speaker(s)

Chaitanya  Koduri, DDS, MHS

Chaitanya Koduri, DDS, MHS

Director, International Government and Regulatory Engagement, US Pharmacopeia, United States

Onshoring in the Americas: Health Canada Perspectives on Building Resilient Medicine Supply Chains

Maria  Amaya, MS

Maria Amaya, MS

Lead External Advocacy, North America , Genentech, A Member of the Roche Group, United States

From Reactive to Proactive: The Role of Canada in Harmonizing Global Shortage Prevention Requirements

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.